119 related articles for article (PubMed ID: 9525959)
1. Identification and partial characterization of factor Va heavy chain kinase from human platelets.
Kalafatis M
J Biol Chem; 1998 Apr; 273(14):8459-66. PubMed ID: 9525959
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of factor Va and factor VIIIa by activated platelets.
Kalafatis M; Rand MD; Jenny RJ; Ehrlich YH; Mann KG
Blood; 1993 Feb; 81(3):704-19. PubMed ID: 8427963
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
Kalafatis M; Rand MD; Mann KG
J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
[TBL] [Abstract][Full Text] [Related]
5. Platelet coagulation factor Va: the major secretory platelet phosphoprotein.
Rand MD; Kalafatis M; Mann KG
Blood; 1994 Apr; 83(8):2180-90. PubMed ID: 8161784
[TBL] [Abstract][Full Text] [Related]
6. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
Egan JO; Kalafatis M; Mann KG
Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
[TBL] [Abstract][Full Text] [Related]
7. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.
Nicolaes GA; Tans G; Thomassen MC; Hemker HC; Pabinger I; Varadi K; Schwarz HP; Rosing J
J Biol Chem; 1995 Sep; 270(36):21158-66. PubMed ID: 7673148
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of echinoderm casein kinase II. Regulation by protein kinase C.
Sanghera JS; Charlton LA; Paddon HB; Pelech SL
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):829-37. PubMed ID: 1590772
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C.
Camire RM; Kalafatis M; Simioni P; Girolami A; Tracy PB
Blood; 1998 Apr; 91(8):2818-29. PubMed ID: 9531592
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
[TBL] [Abstract][Full Text] [Related]
11. Loss of membrane-dependent factor Va cleavage: a mechanistic interpretation of the pathology of protein CVermont.
Lu D; Kalafatis M; Mann KG; Long GL
Blood; 1994 Aug; 84(3):687-90. PubMed ID: 8043858
[TBL] [Abstract][Full Text] [Related]
12. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.
Gould WR; Silveira JR; Tracy PB
J Biol Chem; 2004 Jan; 279(4):2383-93. PubMed ID: 14594814
[TBL] [Abstract][Full Text] [Related]
13. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
Hockin MF; Kalafatis M; Shatos M; Mann KG
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
[TBL] [Abstract][Full Text] [Related]
14. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.
Segers K; Dahlbäck B; Rosing J; Nicolaes GA
J Biol Chem; 2008 Aug; 283(33):22573-81. PubMed ID: 18519572
[TBL] [Abstract][Full Text] [Related]
15. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the molecular defect in factor VR506Q.
Kalafatis M; Bertina RM; Rand MD; Mann KG
J Biol Chem; 1995 Feb; 270(8):4053-7. PubMed ID: 7876154
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human casein kinase II. A study with the complete set of subunits (alpha, alpha' and beta), site-directed autophosphorylation mutants and a bicistronically expressed holoenzyme.
Bodenbach L; Fauss J; Robitzki A; Krehan A; Lorenz P; Lozeman FJ; Pyerin W
Eur J Biochem; 1994 Feb; 220(1):263-73. PubMed ID: 8119294
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of protein kinase CKII isoforms in HeLa cells. Isoform-specific differences in rates of assembly from catalytic and regulatory subunits.
Chester N; Yu IJ; Marshak DR
J Biol Chem; 1995 Mar; 270(13):7501-14. PubMed ID: 7706297
[TBL] [Abstract][Full Text] [Related]
19. Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein C.
Barhoover MA; Kalafatis M
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):317-24. PubMed ID: 21467919
[TBL] [Abstract][Full Text] [Related]
20. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V.
Samis JA; Garrett M; Manuel RP; Nesheim ME; Giles AR
Blood; 1997 Aug; 90(3):1065-74. PubMed ID: 9242537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
